Skip to Main Content
our new site.
NLM Technical Bulletin
Full Text View
No Study Results Posted
Efficacy of Lapaquistat Acetate Alone and With Ezetimibe in Subjects With Primary Dyslipidemia.
This study has been completed.
Study NCT00268697 Information provided by Takeda Global Research & Development Center, Inc.
First Received on December 20, 2005. Last Updated on May 23, 2012
History of Changes
Related Studies can be found by searching for the Conditions, Interventions, and Sponsors found in this study:
Conditions listed in this trial
Additional conditions recognized in this trial
More general conditions related to this trial
Lipid Metabolism Disorders
Interventions listed in this trial
Lapaquistat acetate and ezetimibe
More general drug interventions related to this trial
Lipid Regulating Agents
Molecular Mechanisms of Pharmacological Action
Sponsors listed in this trial
Takeda Global Research & Development Center, Inc.
Back to top of Main Content
Contact Help Desk
Lister Hill National Center for Biomedical Communications
U.S. National Library of Medicine
U.S. National Institutes of Health
U.S. Department of Health & Human Services
Freedom of Information Act
Links to all studies - primarily for crawlers